Form D · Pharmaceuticals
Spotlight Innovation, Inc.
West Des Moines, IA · CIK 0001388486
Offering snapshot reported Dec 6, 2016 · SEC filing
- Reported sold
- $1.38M Offering amount: $2.5M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 31, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 6, 2016 | Initial | $1,382,000 | No comparison | 17 | SEC filing |
| Nov 19, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 19, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 28, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275740
Convertible Promissory Note
Source: Form D, filed Dec 6, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cristopher Grunewald | Director, Executive |
| John Krohn | Director |
| Craig Lang | Director |
| W Illiam Pim | Executive |
| William Pim | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6750 Westown Parkway Suite 200 226
West Des Moines, IA, 50266
West Des Moines, IA, 50266